Healthcare - Biotechnology - NASDAQ - US
$ 93.17
-4.31 %
$ 4.52 B
Market Cap
-14.16
P/E
Price Target
Average
34.16%
Revenue Forecast
Estimate
65.78%
EBIT
Estimate
41.56%
Net Income
Estimate
48.14%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Axsome Therapeutics, Inc.
Wall Street analysts predict an average 1-year price target for AXSM of $125 , with forecasts ranging from a low of $106 to a high of $180 .
AXSM Lowest Price Target
Wall Street Target
106 USD
13.77%
AXSM Average Price Target
Wall Street Target
125 USD
34.16%
AXSM Highest Price Target
Wall Street Target
180 USD
93.20%
REVENUE FORECAST
Revenue Forecast Chart AXSM
EBIT FORECAST
EBIT Forecast Chart AXSM
NET INCOME FORECAST
Net Income Chart AXSM